Table 1.
Patient Characteristics | SARS-CoV-2 Undetected (n = 57) |
SARS-CoV-2 Detected (n = 59) |
---|---|---|
Age | 60.2 (15~91) | 70.7 (31~91) |
Gender [Number (%)] Male Female |
38 (66.7) 19 (33.3) |
48 (81.4) 11 (18.6) |
Outcomes [Number (%)] Died Discharged Transferred Undischarged NA |
5 (8.8) 36 (63.1) 8 (14.0) 3 (5.3) 5 (8.8) |
14 (23.7) 27 (45.8) 13 (22.0) 4 (6.8) 1 (1.7) |
Severity [Number (%)] ICU UnICU |
17 (29.8) 40 (70.2) |
32 (54.2) 27 (45.8) |
Symptoms [Number (%)] Chest.Pain Cough Cough up Phlegm (CuP) Diarrhoea Fever Loss of Appetite (LoA) Vomiting |
9 (15.8) 42 (73.7) 36 (63.2) 7 (12.3) 38 (66.7) 15 (26.3) 8 (14.0) |
10 (16.9) 53 (89.8) 51 (86.4) 18 (30.5) 48 (81.4) 26 (44.1) 9 (15.3) |
Comorbidities [Number (%)] Coronary Artery Disease (CAD) Chronic Lung Disease (CLD) Diabetes Hyperlipidemia Hypertension Other infectious disease (OID) Tumor |
16 (28.1) 4 (7.0) 14 (24.6) 0 (0) 18 (31.6) 4 (7.0) 10 (17.5) |
31 (52.5) 7 (11.9) 16 (21.7) 1 (1.7) 32 (54.2) 4 (6.8) 14 (23.7) |
Treatment [Number (%)] Antibiotic therapy (ABT) Antiviral therapy (AVT) ECMO Hormone therapy (HormT) Immunoglobulin therapy (IgT) Invasive ventilation (IV) Non-Invasive ventilation (NIV) |
44 (77.2) 11 (19.3) 1 (1.75) 20 (35.09) 8 (14.04) 13 (22.81) 15 (26.32) |
50 (84.7) 49 (83.1) 0 (0) 42 (71.2) 18 (30.5) 39 (66.1) 23 (40.0) |